相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis
Pritikanta Paul et al.
MUSCLE & NERVE (2021)
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
Adam Amlani et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
Nika Mohannak et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2019)
Sensitivity and clinical utility of the anti-cytosolic 5′-nucleotidase 1A (cN1A) antibody test in sporadic inclusion body myositis: Report of 40 patients from a single neuromuscular center
Kevin J. Felice et al.
NEUROMUSCULAR DISORDERS (2018)
Five-year history of dysphagia as a sole initial symptom in inclusion body myositis
Saori Shibata et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Pathomechanisms of Anti-Cytosolic 5′-Nucleotidase 1A Autoantibodies in Sporadic Inclusion Body Myositis
Nozomu Tawara et al.
ANNALS OF NEUROLOGY (2017)
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
J. B. Lilleker et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases
Megan K. Herbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement
N. A. Goyal et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases
Thomas E. Lloyd et al.
ARTHRITIS CARE & RESEARCH (2016)
Epidemiology of sporadic inclusion body myositis
Oyvind Molberg et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
ANTI- C N1A ANTIBODIES IN SOUTH AUSTRALIAN PATIENTS WITH INCLUSION BODY MYOSITIS
Vidya S. Limaye et al.
MUSCLE & NERVE (2016)
Interventions for dysphagia in long-term, progressive muscle disease
Katherine Jones et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis
Sabine L. Kramp et al.
AUTOIMMUNITY HIGHLIGHTS (2016)
Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility
Megan K. Herbert et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
MAGNETIC RESONANCE IMAGING PATTERN RECOGNITION IN SPORADIC INCLUSION-BODY MYOSITIS
Giorgio Tasca et al.
MUSCLE & NERVE (2015)
CYTOPLASMIC 5′-NUCLEOTIDASE AUTOANTIBODIES INCLUSION BODY MYOSITIS: ISOTYPES AND DIAGNOSTIC UTILITY
Steven A. Greenberg
MUSCLE & NERVE (2014)
Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis
H. Benjamin Larman et al.
ANNALS OF NEUROLOGY (2013)
Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis
Helma Pluk et al.
ANNALS OF NEUROLOGY (2013)
188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands
M. R. Rose
NEUROMUSCULAR DISORDERS (2013)
Dysphagia in Inflammatory Myopathy: Self-report, Incidence, and Prevalence
Kylie Patricia Mulcahy et al.
DYSPHAGIA (2012)
Pharyngeal Dysphagia in Inflammatory Muscle Diseases Resulting from Impaired Suprahyoid Musculature
P. Claire Langdon et al.
DYSPHAGIA (2012)
Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis
Mohammad Salajegheh et al.
PLOS ONE (2011)
Detecting dysphagia in inclusion body myositis
F. M. Cox et al.
JOURNAL OF NEUROLOGY (2009)
Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis
Merrilee Needham et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
C. E. Jackson et al.
MUSCLE & NERVE (2008)
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo
UA Badrising et al.
ANNALS OF NEUROLOGY (2002)
A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM
MC Dalakas et al.
NEUROLOGY (2001)
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study
MC Walter et al.
JOURNAL OF NEUROLOGY (2000)
分享论文
